El arbitraje OXI

Mu�oz, Xavier Castro
October 2006
Vistazo;10/5/2006, Issue 939, p29
No abstract available.


Related Articles

  • Medidas provisionales en la solución de controversias de inversión. González Napolitano, Silvina S. // ICSID Review: Foreign Investment Law Journal;Fall2016, Vol. 31 Issue 3, p508 

    En los procesos contenciosos internacionales, incluido el arbitraje, las medidas provisionales constituyen un medio al que cualquiera de las partes litigantes puede recurrir, en caso de urgencia, para preservar los derechos en disputa, o vinculados al proceso, asícomo para impedir cualquier...

  • Francisco González de Cossío, Arbitraje de inversión (Editorial Porrúa 2009). Grigera Naón, Horacio A. // ICSID Review: Foreign Investment Law Journal;Nov2010, Vol. 25 Issue 2, p504 

    The article reviews the book "Arbitraje de inversión," by Francisco González de Cossío.

  • Oxy Bump Takes Wraps Off New Nasal Spray at ECRM.  // MMR;2/11/2013, Vol. 30 Issue 3, p26 

    The article previews the Oxy Bump nasal spray from Oxy Bump Corp.

  • Oxy buys Phenolics.  // Chemical Week;4/6/94, Vol. 154 Issue 13, p6 

    Reports on OxyChem's acquisition of the thermoset business of CanadianOxy Chemicals Limited. Operations of CanadianOxy Chemicals.

  • Oxy to release tenders for Idd el-Shargi field development. BAXTER, KEVIN // MEED: Middle East Economic Digest;11/22/2013, Vol. 57 Issue 47, p9 

    The article reports on the plan of Occidental Petroleum Corp. (Oxy) to release the majority of tenders for the phase 5 expansion of its Idd el-Shargi North Dome field in Qatar in 2014. In 1994, Qxy signed a production-sharing agreement with Qatar Petroleum to operate the offshore oil field. Also...

  • OxyContin Marketing Tactics Under Attack. Wechsler, Jill // Pharmaceutical Executive;Mar2002, Vol. 22 Issue 3, p28 

    Reports the criticisms on the pharmaceutical advertising of OxyContin from Purdue Pharma. Move of Purdue in promoting responsible prescription of Oxy; Accounts on the withdrawal of the Oxy journal advertising; Revision of Oxy formulation.

  • Oxy Clinical Hydrating Therapy.  // Cosmetics & Toiletries;Dec2010, Vol. 125 Issue 12, p17 

    The article evaluates the Oxy Clinical Hydrating Therapy cream.

  • The OxyS regulatory RNA represses rpoS translation and binds the Hfq (HF-I) protein. Zhang, Aixia; Altovia, Shoshy; Tiwari, Anita; Argaman, Liron; Hengge-Aronis, Regine; Storz, Gisela // EMBO Journal;10/15/98, Vol. 17 Issue 20, p6061 

    The OxyS regulatory RNA integrates the adaptive response to hydrogen peroxide with other cellular stress responses and protects against DNA damage. Among the OxyS targets is the rpoS-encoded σs subunit of RNA polymerase. σs is a central regulator of genes induced by osmotic stress,...

  • Fire prevented in European IT Centre.  // International Fire & Security Product News;Aug2004, Vol. 29 Issue 4, p26 

    Reports that the European headquarter of Parker Hannifin Corp. has chosen the OxyReduct system of WAGNER UK in August 2004 to provide fire prevention. Reason for choosing OxyReduct; Information on OxyReduct.

  • OxyChem to Acquire Vulcan Chemicals. Sim, Peck Hwee // Chemical Week;10/20/2004, Vol. 166 Issue 34, p8 

    Reports on the decision of OxyChem to acquire Vulcan Chemicals. Businesses of Vulcan that will be acquired by OxyChem; Basis for the payment to be made to Vulcan; Financial performance of Vulcan for 2002 and 2003; Significance of the acquisition to OxyChem.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics